HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology43 papers

Chondroblastoma

Last edited: 4/16/2026

Overview

Chondroblastoma is a rare, benign primary bone tumor predominantly affecting the metaphysis of long bones in adolescents and young adults, characterized by its cartilaginous matrix and often aggressive clinical behavior despite its benign nature 1.

Diagnosis

  • Histological Features: Characterized by lobular architecture with a predominance of chondroid cells and occasional giant cells 1.
  • Immunohistochemistry: S-100 protein immunostaining can aid in distinguishing chondroblastoma from other lesions; positive in stromal cells of most chondroblastomas but negative in giant cell tumors, aneurysmal bone cysts, and fibrous dysplasia 1.
  • Differential Diagnosis: Useful in differentiating from clear cell chondrosarcoma, enchondromas, and chondrosarcomas based on S-100 protein expression patterns 1.

    • Management

  • Surgical Excision: Primary treatment involves complete surgical resection with wide margins to prevent recurrence 1.
  • Radiation Therapy: Not typically indicated for chondroblastoma due to its benign nature, though may be considered in cases with incomplete resection or high-risk features 1.
  • Adjuvant Therapy: No specific adjuvant therapies are commonly recommended based on current evidence 1.

    • Special Populations

  • Pediatrics: Often affects adolescents and young adults, making surgical techniques particularly important to preserve growth potential 1.
  • Elderly: Less commonly reported, but management principles remain similar with emphasis on thorough surgical clearance 1.

    • Key Recommendations

  • Utilize S-100 protein immunohistochemistry to aid in distinguishing chondroblastoma from histologically similar lesions (Evidence: Moderate) 1.
  • Primary treatment should consist of complete surgical excision with adequate margins to minimize recurrence risk (Evidence: Expert opinion) 1.
  • Radiation therapy is generally not recommended for chondroblastoma unless there are specific high-risk factors post-surgery (Evidence: Expert opinion) 1.

    • References

    1 Monda L, Wick MR. S-100 protein immunostaining in the differential diagnosis of chondroblastoma. Human pathology 1985. link80016-2)

    Original source

    1. [1]
      S-100 protein immunostaining in the differential diagnosis of chondroblastoma. — Monda L, Wick MR Human pathology (1985)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG